Man Group PLC Fibrogen Inc Transaction History

Man Group PLC

$36 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$15.95 - $25.18 $398,606 - $629,273	24,991 New	24,991 $466,000
Q3 2022 Nov 14, 2022	SELL	$11.4 - $14.6 $123,234 - $157,826	-10,810 Reduced 47.0%	12,190 $159,000
Q2 2022 Aug 15, 2022	SELL	$7.94 - $12.96 $60,344 - $98,496	-7,600 Reduced 24.84%	23,000 $243,000
Q1 2022 May 16, 2022	BUY	$12.02 - $16.79 $367,812 - $513,774	30,600 New	30,600 $368,000
Q2 2021 Aug 16, 2021	SELL	$18.57 - $35.68 $299,348 - $575,161	-16,120 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$31.0 - $55.72 $1.81 Million - $3.26 Million	-58,510 Reduced 78.4%	16,120 $560,000
Q4 2020 Feb 16, 2021	SELL	$37.09 - $48.97 $311,667 - $411,494	-8,403 Reduced 10.12%	74,630 $2.77 Million
Q3 2020 Nov 16, 2020	SELL	$40.47 - $45.5 $2.99 Million - $3.36 Million	-73,845 Reduced 47.07%	83,033 $3.42 Million
Q2 2020 Aug 14, 2020	BUY	$32.57 - $42.83 $2.96 Million - $3.9 Million	90,966 Added 138.01%	156,878 $6.36 Million
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $3.37 Million - $6.64 Million	-144,516 Reduced 68.68%	65,912 $2.29 Million
Q4 2019 Feb 18, 2020	BUY	$34.58 - $48.06 $3.6 Million - $5 Million	104,112 Added 97.93%	210,428 $9.03 Million
Q3 2019 Nov 14, 2019	SELL	$36.98 - $48.45 $9.25 Million - $12.1 Million	-250,013 Reduced 70.16%	106,316 $3.93 Million
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $2.24 Million - $3.54 Million	63,797 Added 21.81%	356,329 $16.1 Million
Q1 2019 May 15, 2019	SELL	$42.83 - $59.91 $3.22 Million - $4.51 Million	-75,289 Reduced 20.47%	292,532 $15.9 Million
Q4 2018 Feb 14, 2019	BUY	$37.97 - $60.16 $4.21 Million - $6.68 Million	110,968 Added 43.2%	367,821 $17 Million
Q3 2018 Nov 14, 2018	BUY	$56.3 - $67.25 $8.71 Million - $10.4 Million	154,719 Added 151.49%	256,853 $15.6 Million
Q2 2018 Aug 14, 2018	BUY	$44.9 - $64.95 $2.34 Million - $3.39 Million	52,136 Added 104.28%	102,134 $6.39 Million
Q1 2018 May 15, 2018	BUY	$45.35 - $61.65 $2.27 Million - $3.08 Million	49,998 New	49,998 $2.31 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account